ReviewVirulence2026
Mechanical forces in bacterial pathogenesis: Sensing, tropism, and intervention.
Review in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial pathogenesis unfolds within mechanically complex host niches, yet physical forces are frequently overlooked as active drivers of virulence. Here, we argue that mechanical cues-shear, confinement, and matrix rheology-serve as essential regulatory inputs that dynamically reprogram bacterial physiology. We propose a multi-scale framework connecting force-dependent receptor kinetics and envelope-stress signaling to community-level biofilm viscoelasticity. This synthesis elucidates how bacteria interpret the specific force landscapes of human tissues, providing a mechanistic rationale for tissue-tropism that biochemical models alone cannot resolve. Finally, we posit that the "physicality" of infection presents an unexploited therapeutic frontier. By outlining strategies to target mechanotransduction nodes or exploit biofilm mechanical fragilities, we demonstrate how mechanics-based interventions offer orthogonal strategies to bypass antimicrobial resistance, shifting the paradigm from chemical inhibition to physical disruption.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.